Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-03-12 00:29 |
Amendment No. 2 to Form F-1
|
English | 1.8 MB | ||
| 2020-03-12 00:29 |
Amendment No. 2 to Form F-1
|
English | 38.6 KB | ||
| 2020-03-11 00:29 |
Form F-1/A Registration Statement Under the Securities Act of 1933 Kitov Pharma…
|
English | 3.9 MB | ||
| 2020-03-11 00:29 |
Form F-1/A Registration Statement Under the Securities Act of 1933 Kitov Pharma…
|
English | 38.5 KB | ||
| 2020-02-24 17:09 |
Expands Planned NT-219 Clinical Program for Difficult to Treat Cancers
|
English | 111.7 KB | ||
| 2020-02-24 17:09 |
Expands Planned NT-219 Clinical Program for Difficult to Treat Cancers
|
English | 38.5 KB | ||
| 2020-02-16 10:13 |
Schedule 13G filing with the SEC by Pontifax (Israel) II L.P
|
English | 173.7 KB | ||
| 2020-02-16 10:13 |
Schedule 13G filing with the SEC by Pontifax (Israel) II L.P
|
English | 38.3 KB | ||
| 2020-02-11 15:09 |
Provides Corporate Update and Reports Full-Year 2019 Financial
|
English | 194.0 KB | ||
| 2020-02-11 15:09 |
Provides Corporate Update and Reports Full-Year 2019 Financial
|
English | 38.6 KB | ||
| 2020-02-11 15:00 |
Corporate Update and Reports Full-Year 2019 Financial Results
|
English | 293.0 KB | ||
| 2020-02-11 15:00 |
Corporate Update and Reports Full-Year 2019 Financial Results
|
English | 38.2 KB | ||
| 2020-02-03 16:24 |
Receives Issue Notification for a U.S. Patent Covering its anti-CEACAM1 Cancer …
|
English | 77.1 KB | ||
| 2020-02-03 16:24 |
Receives Issue Notification for a U.S. Patent Covering its anti-CEACAM1 Cancer …
|
English | 38.5 KB | ||
| 2020-01-27 14:00 |
Kitov Pharma Receives Notice of Intention to Grant European Patent Covering the…
|
English | 125.9 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
